Gwendalyn J. Randolph, PhD, director of the Division of Immunobiology at the School of Medicine, has been chosen as a 2015 recipient of the NIH Director’s Pioneer Award. The award challenges investigators to develop groundbreaking approaches that have a high impact on a broad area of biomedical or behavioral science. Randolph is one of 13 Pioneer Award winners this year.
Andrey Shaw, MD, the Emil R. Unanue Professor of Immunobiology in the Department of Pathology and Immunology and director of the Division of Immunobiology at Washington University School of Medicine in St. Louis, has received a one-year, $84,583 grant from the National Institutes of Health (NIH) and Confluence Life Sciences Inc. for research titled “Development of TAK1 Inhibitors to Treat Pancreatic Cancer.”
In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at the School of Medicine including senior author Robert Schreiber, PhD, has brought the approach one step closer to reality.